Effects of aromatase inhibitor therapy on visceral adipose tissue area and cardiometabolic health in postmenopausal women with early and locally advanced breast cancer.
Yee-Ming Melody CheungRudolf HoermannKaren VanDamian WuJenny HealyMichael ChaoShane WhiteBelinda YeoJeffrey ZajacMathis GrossmannPublished in: Clinical endocrinology (2022)
These data provide reassurance that over the initial 12 months of AI therapy, AI treatment is not associated with metabolically adverse changes in body composition, hepatic steatosis or vascular reactivity. The impact of extended AI therapy on cardiometabolic health requires further study.
Keyphrases
- body composition
- postmenopausal women
- bone mineral density
- adipose tissue
- healthcare
- artificial intelligence
- public health
- locally advanced
- mental health
- squamous cell carcinoma
- insulin resistance
- resistance training
- rectal cancer
- radiation therapy
- machine learning
- health information
- clinical trial
- neoadjuvant chemotherapy
- high fat diet
- type diabetes
- climate change
- skeletal muscle
- social media
- human health
- replacement therapy
- bone marrow
- health promotion